24 December 2021

Merry Christmas 2021

Continue reading
#

Ardigen's feed news

Merry Christmas 2021
24 December 2021
Merry Christmas 2021
Continue reading
Prof. Olivera Finn joined Ardigen’s Scientific Board to support the development of AI-driven technology platforms for cancer vaccines and cell therapies.
4th November 2021
Prof. Olivera Finn joined Ardigen’s Scientific Board to support the development of AI-driven technology platforms for cancer vaccines and cell therapies.
Continue reading
Ardigen has received funding for the development of the AI-powered Microbiome Platform.
25 October 2021
Ardigen has received funding for the development of the AI-powered Microbiome Platform.
Continue reading
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
7 september 2021
Dr. Aleksandra Walczak joined Ardigen’s Scientific Board to support the development of AI platforms for the discovery of cell therapies.
Continue reading
Ardigen obtained a Great Place to Work certification
19 July 2021
Ardigen obtained a Great Place to Work certification
Continue reading
Ardigen and OncoArendi join forces for research collaboration
24 May 2021
Ardigen and OncoArendi join forces for research collaboration
Continue reading
Assessing off-target toxicity of cellular immunotherapies - CIMT 2021 poster
13 May 2021
Assessing off-target toxicity of cellular immunotherapies - CIMT 2021 poster
Continue reading
Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery
15 April 2021
Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery
Continue reading
Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet
April 13, 2021
Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet
Continue reading
Go up